Inspire Medical Systems, Inc. Retained Earnings
Inspire Medical Systems, Inc. (INSP) had Retained Earnings of -$157.47 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-03
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$157.47M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$157.79M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$146.49M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$282.58M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$157.47M 10-Q · filed 2026-08-03 |
| 2026-03-31 | -$157.79M 10-Q · filed 2026-05-04 |
| 2025-12-31 | -$146.49M 10-Q · filed 2026-08-03 |
| 2025-09-30 | -$282.58M 10-Q · filed 2025-11-03 |
| 2025-06-30 | -$292.51M 10-Q · filed 2025-08-04 |
| 2025-03-31 | -$288.92M 10-Q · filed 2025-05-05 |
| 2024-12-31 | -$291.91M 10-K · filed 2026-02-13 |
| 2024-09-30 | -$327.14M 10-Q · filed 2024-11-04 |
| 2024-06-30 | -$345.63M 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$355.43M 10-Q · filed 2024-05-07 |
| 2023-12-31 | -$345.42M 10-K · filed 2025-02-10 |
| 2023-09-30 | -$360.19M 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$351.65M 10-Q · filed 2023-08-01 |
| 2023-03-31 | -$339.69M 10-Q · filed 2023-05-02 |
| 2022-12-31 | -$324.27M 10-K · filed 2024-02-09 |
| 2022-09-30 | -$327.42M 10-Q · filed 2022-11-01 |
| 2022-06-30 | -$310.57M 10-Q · filed 2022-08-02 |
| 2022-03-31 | -$296.08M 10-Q · filed 2022-05-03 |
| 2021-12-31 | -$279.39M 10-K · filed 2023-02-10 |
| 2021-09-30 | -$277.00M 10-Q · filed 2021-11-02 |
| 2021-06-30 | -$266.65M 10-Q · filed 2021-08-03 |
| 2021-03-31 | -$253.56M 10-Q · filed 2021-05-04 |
| 2020-12-31 | -$237.35M 10-K · filed 2022-02-15 |
| 2020-09-30 | -$229.86M 10-Q · filed 2020-11-02 |
| 2020-06-30 | -$219.48M 10-Q · filed 2020-08-04 |
| 2020-03-31 | -$196.39M 10-Q · filed 2020-05-05 |
| 2019-12-31 | -$180.16M 10-K · filed 2021-02-24 |
| 2019-09-30 | -$171.08M 10-Q · filed 2019-11-05 |
| 2019-06-30 | -$162.83M 10-Q · filed 2019-08-06 |
| 2019-03-31 | -$155.18M 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$146.91M 10-K · filed 2020-02-25 |
| 2018-09-30 | -$142.13M 10-Q · filed 2018-11-06 |
| 2018-06-30 | -$137.44M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$131.59M 10-Q · filed 2018-06-07 |
| 2017-12-31 | -$125.08M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |